Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
BMJ Quality & Safety
|
April 30, 2021
Effects of a refined evidence-based toolkit and mentored implementation on medication reconciliation at 18 hospitals: results of the MARQUIS2 study
Jeffrey L Schnipper, Harry Reyes Nieva, Meghan Mallouk, et al.
Clinical Transplantation
|
June 24, 2023
Safety and utility of indwelling pleural catheters in lung transplant recipients
Anil J Trindade, Robert J Lentz, Whitney D Gannon, et al.
Frontiers in Physiology
|
October 25, 2017
Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib
Svantje Sobotta, Andreas Raue, Xiaoyun Huang, et al.
Nature Communications
|
July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age
Birgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
Cancers
|
April 30, 2021
Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations
Birgit Burkhardt, Mary Taj, Nathalie Garnier, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
BMJ Quality & Safety
|
April 30, 2021
Effects of a refined evidence-based toolkit and mentored implementation on medication reconciliation at 18 hospitals: results of the MARQUIS2 study
Jeffrey L Schnipper, Harry Reyes Nieva, Meghan Mallouk, et al.
Clinical Transplantation
|
June 24, 2023
Safety and utility of indwelling pleural catheters in lung transplant recipients
Anil J Trindade, Robert J Lentz, Whitney D Gannon, et al.
Frontiers in Physiology
|
October 25, 2017
Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib
Svantje Sobotta, Andreas Raue, Xiaoyun Huang, et al.
Nature Communications
|
July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age
Birgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
Cancers
|
April 30, 2021
Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations
Birgit Burkhardt, Mary Taj, Nathalie Garnier, et al.
Page
of 5